Global market access teams in Pharma and Medtech are tasked with ensuring local affiliates always have access to the latest product evidence and value narratives. But as we know, different markets have different needs and requirements. Local affiliates may need to reference different published literature or economic models in their value presentations, making it a challenge for global teams to ensure that the right source materials are being used at the local level.

So, how can global teams efficiently manage and share these resources, ensuring consistency and alignment of messaging across all markets?

In this webinar, Sophie Streeton (Associate Director – Global Market Access) and Andrew Spencer (Director – Digital) will explore how a centralised platform can solve this challenge, helping global teams easily manage and share global value dossiers (GVDs), presentations, and other critical market access materials. We’ll explore ways to:

• Centralise materials for multiple products and markets – Streamline content management across various products and geographies, all in one place
• Ensure affiliates have up-to-date evidence – Ensure your local teams always have the latest GVDs and supporting materials at their fingertips
• Connect global and local evidence – Easily link market-specific data to your centralised global resources, enabling informed decision-making at every level
• Understand material usage – Leverage dynamic reporting to see which resources are most valuable to local teams

The webinar will include an interview with Tim Styche (Market Access & Health Outcomes Director, Smith+Nephew), who will share his real-world experiences with our Global Value Platform. Tim will discuss how the platform has enabled his team to ensure approved global materials are readily accessible to local teams, boosting productivity and streamlining market access efforts.

We will also provide a brief demo showcasing how our platform can deliver on these benefits – and how it’s designed to help teams like yours succeed in managing and sharing resources more effectively.

Register now to join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May or to access the recording later!

Please do register, even if you can’t attend on the day, as all registrants will receive the recording after the event.

The webinar is free and open to all market access, evidence strategy, HEOR, and value communication teams in Pharma and Medtech companies. Some colleagues from other organisations may attend at the discretion of Petauri Evidence.

Watch the recording:

During the webinar, the panellists explored:

• The evidence required for health economic modelling, with a focus on partitioned survival modelling for oncology
• Challenges posed by immature data or single-arm studies
• How RWD can fill the gap
• What RWD look like in practice
• How RWD and RWE can support the HTA process
• How RWD can be used to generate external control arms
• Using RWD in an HTA submission – the assessor’s perspective

The Mtech Access Team were delighted to be presenting this webinar alongside colleagues from Arcturis and Delta Hat.

In an earlier rare disease market access webinar, we explored the challenges facing orphan medicines entering key European markets. Here, we explore some of the markets that can be neglected or forgotten about by Global teams. The rare markets if you like.

Our Global Market Access experts explore contrasting regions to showcase the significant differences between international markets when it comes to:

• Overall and rare disease patient populations
• Access inequalities
• Time to diagnosis
• Access to innovation timelines
• Healthcare funding
• Health technology assessment frameworks

Robert Taaffe (Consultant – Global Market Access) presents his research into the market access conditions in the MENA regions, with a focus on the rare disease reimbursement landscape in growth markets in Egypt, Saudi Arabia, and the United Arab Emirates.

Michelle James (Associate Consultant – Global Market Access) showcases market access and reimbursement routes in the more established, yet smaller populations in the Nordic regions. Michelle will focus on access in Denmark, Sweden, and Norway.

Clare Foy (Director – Global Market Access) leads our discussion on the opportunities and challenges of launching in markets with different conditions and requirements, and how this should play into your overarching Global market access strategy.

This recording was first broadcast live in November 2023 for the Royal Society of Biology – Wessex Branch.

To learn more about the work of our Health Economists, or to arrange a similar lecture or workshop for your organisation, please email info@mtechaccess.co.uk.

For information about the health economics career pathway at Mtech Access, email careers@mtechaccess.co.uk.

What does a best-in-class value communication tool look like in 2022? What are the key considerations when developing a new payer value toolkit? And what should Pharma and Medtech companies look for in a consultancy partner?

For this webinar we brought together representatives from our health economics (Anthony Bentley), value communication (Lydia Crowe), design (Ryan Booth) and digital (Rob Pitt) teams to showcase how a typical Mtech Access project team collaborate to create interactive digital tools, with Emily Mair (Associate Consultant) acting as host presenter.

Using our updated Digital Value Communication Tool Demo as a case study, our panellists explained how we craft our tools to meet the needs of three key groups:

• Those who commission the tools – e.g. market access, brand and commercial leaders
• The end-users – e.g. key account managers
• The audience – e.g. payers and other healthcare decision-makers

Watch the webinar recording to benchmark your payer value toolkits against what’s possible and explore how great design and interactivity can support your communication with healthcare decision-makers.

Meet our panellists:

Who are Mtech Access?

Mtech Access are a global market access and HEOR consultancy, supporting Pharmaceutical and Medtech companies with every step of the market access journey. With health economics, market access and digital expertise in-house, we create market-leading localised budget impact models and value proposition toolkits. Our digital payer value toolkits allow field-based teams to concisely communicate product value and the impact of local uptake to payers and healthcare decision makers. Our tools are interactive, engaging, and flexible, allowing account managers to run tailored scenarios according to the audience.

We are delighted to showcase some of this knowledge and experience with you in this webinar.

Listen to the podcast:

This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights  – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.